Major depressive disorder and co-morbid chronic pain, a costly condition

被引：0
|
作者：
Hunkeler, EM
Arnow, BA
Fireman, B
Lee, J
Robinson, R
Blasley, C
Constantino, MJ
Kraemer, BC
Haywood, C
Dea, R
Swindle, RW
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] Stanford Alcohol & Drug Treatment Ctr, Stanford, CA USA
[4] Stanford Med Ctr, Stanford, CA USA
[5] Stanford Univ, Stanford, CA 94305 USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2004年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S336 / S336
页数：1
相关论文
共 50 条
  • [41] Evaluation of the HAM-D17 following eszopiclone treatment in patients with insomnia co-morbid with major depressive disorder or generalized anxiety disorder
    Fava, M.
    Pollack, M.
    Montgomery, S.
    Wessel, T.
    Amato, D.
    Krystal, A.
    Hayduk, R.
    McCall, W. V.
    EUROPEAN PSYCHIATRY, 2008, 23 : S360 - S360
  • [42] Chronic trans-astaxanthin treatment exerts antihyperalgesic effect and corrects co-morbid depressive like behaviors in mice with chronic pain
    Jiang, Xi
    Yan, Qizhi
    Liu, Fuhe
    Jing, Changfeng
    Ding, Lianshu
    Zhang, Lijin
    Pang, Cong
    NEUROSCIENCE LETTERS, 2018, 662 : 36 - 43
  • [43] Effectiveness of vortioxetine in patients with major depressive disorder and co-morbid generalized anxiety disorder in routine clinical practice: A subgroup analysis of the RELIEVE study
    Almeida, Susana S.
    Christensen, Michael Cronquist
    Simonsen, Kenneth
    Adair, Michael
    JOURNAL OF PSYCHOPHARMACOLOGY, 2023, 37 (03) : 279 - 288
  • [44] Evaluation of the Hamilton depression scale following eszopiclone treatment for insomnia in patients with insomnia co-morbid with major depressive disorder or generalized anxiety disorder
    Fava, M.
    Pollack, M.
    Rubens, R.
    Amato, D.
    Kostal, A.
    Hayduk, R.
    McCall, W.
    SLEEP, 2007, 30 : A329 - A330
  • [45] Evaluation of the Hamilton depression scale following eszopiclone treatment for insomnia in patients with insomnia co-morbid with major depressive disorder or generalized anxiety disorder
    Fava, Maurizio
    Pollack, Mark
    Rubens, Robert
    Amato, David
    Krystal, Andrew
    Hayduk, Roza
    McCall, W. Vaughn
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 84S - 84S
  • [46] Treatment of co-morbid pain with venlafaxine or desvenlafaxine
    Germain, J. M.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (04) : 308 - 308
  • [47] Treatment of co-morbid pain with milnacipran or duloxetine
    Briley, M.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (04) : 308 - 308
  • [48] Co-morbid anxiety disorders in bipolar disorder and major depression: familial aggregation and clinical characteristics of co-morbid panic disorder, social phobia, specific phobia and obsessive-compulsive disorder
    Goes, F. S.
    McCusker, M. G.
    Bienvenu, O. J.
    MacKinnon, D. F.
    Mondimore, F. M.
    Schweizer, B.
    DePaulo, J. R., Jr.
    Potash, J. B.
    PSYCHOLOGICAL MEDICINE, 2012, 42 (07) : 1449 - 1459
  • [49] Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions
    Aaron, LA
    Buchwald, D
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2003, 17 (04): : 563 - 574
  • [50] Chronic pain and major depressive disorder in the general population
    Ohayon, Maurice M.
    Schatzberg, Alan F.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2010, 44 (07) : 454 - 461
12345